P

Inventor

SIEGEL CRAIG S

US24 patents
⚠️ This page may combine multiple inventors who share the name “SIEGEL CRAIG S”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

GENZYME CORP

23 patents
US5783565AJul 21, 1998

Cationic amphiphiles containing spermine or spermidine cationic group for intracellular delivery of therapeutic molecules

GENZYME CORP123 citations99
US5948767ASep 7, 1999

Cationic amphiphile/DNA complexes

GENZYME CORP271 citations98
US5719131AFeb 17, 1998

Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules

GENZYME CORP119 citations98
US6071890AJun 6, 2000

Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy

GENZYME CORP128 citations97
US5767099AJun 16, 1998

Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules

GENZYME CORP201 citations97
US5925628AJul 20, 1999

Cationic amphiphiles for intracellular delivery of therapeutic molecules

GENZYME CORP66 citations96
US5650096AJul 22, 1997

Cationic amphiphiles for intracellular delivery of therapeutic molecules

GENZYME CORP92 citations96
US5840710ANov 24, 1998

Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules

GENZYME CORP51 citations95
US5935936AAug 10, 1999

Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules

GENZYME CORP85 citations94
US6383814B1May 7, 2002

Cationic amphiphiles for intracellular delivery of therapeutic molecules

GENZYME CORP32 citations92
US5942634AAug 24, 1999

Cationic amphiphiles for cell transfections

GENZYME CORP27 citations92
US5939401AAug 17, 1999

Cationic amphiphile compositions for intracellular delivery of therapeutic molecules

GENZYME CORP37 citations92
US5912239AJun 15, 1999

Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules

GENZYME CORP22 citations92
US5910487AJun 8, 1999

Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules

GENZYME CORP28 citations92
US5747471AMay 5, 1998

Cationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic molecules

GENZYME CORP37 citations92
US5948925ASep 7, 1999

Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids

GENZYME CORP49 citations90
US9518049B2Dec 13, 2016

Salt forms of (S)-quinuclidin-3-yl (2-(2-(4-fluorophenyl)thiazol-4-yl)propan-2-yl)carbamate

GENZYME CORP7 citations84
US10954230B2Mar 23, 2021

Method of preparing glucosylceramide synthase inhibitors

GENZYME CORP4 citations82
US10604518B2Mar 31, 2020

Method of preparing glucosylceramide synthase inhibitors

GENZYME CORP5 citations82
US10065949B2Sep 4, 2018

Method of preparing glucosylceramide synthase inhibitors

GENZYME CORP8 citations82
US9682975B2Jun 20, 2017

Method of preparing glucosylceramide synthase inhibitors

GENZYME CORP10 citations82
US5952516ASep 14, 1999

Cationic amphiphiles containing multiplesteroid lipophilic groups

GENZYME CORP12 citations74
US6331524B1Dec 18, 2001

Organ-specific targeting of cationic amphiphile / DNA complexes for gene therapy

GENZYME CORP11 citations72

SIEGEL CRAIG S

1 patent